The Technical AnalystExchange: EURONEXT Sector: Healthcare Industry: Drug Manufacturers—General
Haw Par Corporation Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% SGD9.76
America/New_York / 17 mai 2024 @ 05:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 160.55 mill |
| EPS: | 0.980 |
| P/E: | 9.96 |
| Earnings Date: | Aug 09, 2024 |
| SharesOutstanding: | 221.37 mill |
| Avg Daily Volume: | 0.0714 mill |
| RATING 2024-05-17 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | ||
| Gr.Profit | n/a | n/a | n/a | n/a | ||
| Ebit | n/a | n/a | n/a | n/a | ||
| Asset | n/a | n/a | n/a | n/a | ||
| Debt | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.58x |
| Company: PE 9.96 | sector: PE 17.08 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.12x |
| Company: PE 9.96 | industry: PE 86.39 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
SGD17.88 (83.22%) SGD8.12 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
SGD 9.68 - 9.84 ( +/- 0.82%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SGD9.76 (0.00% ) |
| Volume | 0.0406 mill |
| Avg. Vol. | 0.0714 mill |
| % of Avg. Vol | 56.85 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For H02.SI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
H02.SI
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.